Viridian Therapeutics
VRDN
#5423
Rank
NZ$1.74 B
Marketcap
$21.42
Share price
-5.22%
Change (1 day)
-20.88%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$7.94

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$8.70. In 2022 the company made an earnings per share (EPS) of -$7.20 an increase over its 2021 EPS that were of -$13.54.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.9410.25%
2022-$7.20-46.83%
2021-$13.54-73.94%
2020-$51.9844.73%
2019-$35.9122.94%
2018-$29.21-27.33%
2017-$40.20-91.47%
2016-$471.15-19.17%
2015-$582.91-75.48%
2014-$2,377582.47%
2013-$348.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA